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S18 Diabetic Nephropathywith diabetic nephropathy and investigate the relationship between
glucagon like peptide-1 receptor agonist and the expression of COX2 in renal
medulla.
Methods: 130 male Sprague Dawley rats were divided into the conventional
feed group (normal group, n Z 30) and high sugar and fat diet fed group
(nZ 100) randomly. Diabetic rats were induced by intraperitoneal injection
of streptozotocin after high sugar and fat diets fed eight weeks. The diabetic
rats (nZ 72) divided into the diabetic nephropathy (DN) group, Low-Liraglu-
tide (L-Lg, 5 mg/kg) group and High-Liraglutide (H-Lg, 10 mg/kg) group. To
measure the blood pressure, the level of sodium, 24-hour urinary sodium
(UNa) and 24-hour urinary 6-keto-prostaglandin F1a (6k-PGF1a). Determina-
tion of the expression of COX2 in renal medullary tissue using immunohisto-
chemistry. Using Western blot technology analysis the expression of COX2
protein in the renal medullary.
Results: Compared with N Group, the blood pressure, the serum sodium and
UNa are increasing, the urinary 6k-PGF1a is decreasing, the renal medulla
expression of COX2 is increasing in DN group (P < 0.05). Compared with
the DN group, the blood pressure, the serum sodium and UNa are decreasing,
the urinary 6k-PGF1a is increasing, the renal medulla expression of COX2 is
still increasing in L-Lg group and H-Lg group (P < 0.05). Compared with L-Lg
group, the renal medulla expression of COX2 is further increasing (P < 0.05).
Conclusion: GLP-1 receptor agonist Liraglutide can reduce the blood pres-
sure, the serum sodium, increase the excretion of 24-hour urinary sodium
excretion in DN rats, and increase the excretion of 24-hour urinary 6k-
PGF1a, and upregulate the expression of COX2 protein in the renal medulla.
The mechanism of GLP-1 receptor agonist regulate blood pressure and wa-
ter-sodium metabolism by activation of COX2.http://dx.doi.org/10.1016/j.hkjn.2015.08.053
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Objective: Compare the efficacy and safety of anticoagulation with
different doses of heparin in the continuous renal replacement therapy
(CRRT) for diabetic nephropathy, confirm the effective dose of anticoagu-
lant in the treatment of CRRT for diabetic nephropathy to provide the basic
data for clinical work.
Methods: 54 patients with diabetic nephropathy were randomly divided into
three groups; group 1 (18 patients, heparin, 0.3 mg/kg), group 2 (18 pa-
tients, heparin, 0.4 mg/kg), group 3 (18 patients, heparin, 0.5 mg/kg). To
evaluate coagulation function, the filter and pipeline were observed; the
activated partial thromboplastin time (APTT) and platelet levels were moni-
tored before or after treatment.
Results: In group 1, the APTT and platelet levels had no significant change
after treatment; in group 2, the APTT extended to 1.5 times with no signif-
icant change of platelet levels; in group 3, the APTT raised obviously, other-
wise, the platelet levels decreased remarkable with significance among
group 1, group 2 and group 3 (P < 0.05).
Conclusion: As for diabetic nephropathy, a larger dose of heparin could in-
crease efficacy and safety of CRRT.http://dx.doi.org/10.1016/j.hkjn.2015.08.054
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Objective: To investigate the effect of irbesartan in regulating the expres-
sion of PINCH-1 in the kidney tissue of diabetes mellitus rat using diabetes
mellitus rat model.
Methods: After establishing rat model of diabetes mellitus, real-time poly-
merase chain reaction (RT-PCR) and Western blot were applied to detect
the expression of PINC-1 in the kidney tissue of diabetes mellitus rat after
irbesartan treatment.Results: RT-PCR shown the PINCH-1 mRNA expression in diabetes mellitus rat
(1.537  0.04) was higher than in the normal rat (1.128  0.03), and
decreased after the treatment of irbesartan (1.246  0.02) (P < 0.05). West-
ern blot showed the expression of PINCH-1 in the kidney tissue of diabetes
mellitus rat with irbesartan treatment (1.159  0.03) (P > 0.05).
Conclusion: Irbesartan could downregulate the expression of PINCH-1 in the
kidney tissue of diabetes mellitus rat.http://dx.doi.org/10.1016/j.hkjn.2015.08.055
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Objective: To analyze the kidney pathogenesis of proteinuria in patients
with type 2 diabetes mellitus.
Methods: Selected 50 cases of type 2 diabetic patients with proteinuria,
all of which were given tests as follows, echocardiography, carotid ultra-
sonography, fundus examination, glomerular filtration rate, renal func-
tion, blood lipids, blood glucose, glycosylated hemoglobin, urine
analysis, 24 hour urinary protein quantitative clinical physical examination
and renal biopsy. According to the pathological results, patients were
divided into diabetic nephropathy group and non-diabetic nephropathy
group.
Results: 48.2% of 50 cases were diagnosed as diabetic nephropathy, while
51.8% were diabetic patients with other glomerular diseases, namely non-
diabetic nephropathy, and in which the highest proportion was focal
segmental glomerulosclerosis. Fasting blood glucose was high in diabetic
nephropathy group (P < 0.05). Cardiac color Doppler ultrasound indicated
that the ejection fraction in the diabetic nephropathy group was signifi-
cantly lower than that in the non-diabetic nephropathy group
(P < 0.05). Carotid artery ultrasonography examination showed that in
diabetic nephropathy group The number of atherosclerotic plaque pa-
tients was significantly higher than that in non-diabetic nephropathy
group, while the intima media thickness (IMT) of the carotid artery in dia-
betic nephropathy group was higher than that in non-diabetic nephropathy
group (P < 0.05). It is worth noting that the non-diabetic nephropathy has
little to do with diabetic retinopathy, which means diabetic retinopathy
has a high sensitivity and specificity for the diagnosis of diabetic nephrop-
athy (P < 0.01).
Conclusion: in the case of type 2 diabetes complicated with urinary protein,
fasting blood glucose, heart shot ejection fraction, carotid atheromatous
plaque and intima-media thickness, and fundus changes could be used as
thereference indexes for the diagnosis of diabetic nephropathy and non-dia-
betic nephropathy, while renal biopsy is an important diagnosis index of dia-
betic kidney disease.http://dx.doi.org/10.1016/j.hkjn.2015.08.056
0281
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Objectives: To evaluate the new pathological classification of diabetic
nephropathy (DN) published by Research Committee of the
Renal Pathology Society in 2010 and to investigate clinical and patholog-
ical predictors of tubulointerstitial injury in new pathological
classification.
Methods: 43 cases with DN performed renal biopsy. Patients were
divided into different groups according to glomerular classification
or interstitial fibrosis and tubular atrophy (IFTA) score by the new
pathological classification. We used X2 test or Fisher’s exact test, Mann-
Whitney U-test, Kruskal-Wallis H-test and Spearman’s correlation to make
comparisons and correlations between the clinical and pathological findings
Diabetic Nephropathy S19and tubulointerstitial injury. Ordinal regression mode was utilized to eval-
uate which clinical factors might be the predictors of IFTA score.
Results: In the groups divided by IFTA score, the patients whose IFTA score
was 3 were younger (95% Cl 1.77 to 33.74, p Z 0.03 vs group with score 0),
have higher level of urinary protein excreation (95% Cl 11.82 to 0.27,
pZ 0.041 vs group with score 0) and greatly lower level of eGFR for patients
in score 3 (95% Cl 35.09 to 73.29, p < 0.01 vs group with score 1). In the cor-
relations, the glomerular class displayed a strong positive correlation with
IFTA [correlation coefficient (r)Z 0.5, PZ 0.001], interstitial inflammation
(rZ 0.79, P < 0.01), serum creatinine (rZ 0.50, P < 0.01) and urinary pro-
tein excretion (r Z 0.35, P Z 0.025). IFTA showed strong negative correla-
tion with Egfr (r Z 0.58, P < 0.01). In the ordinal mode, eGFR (OR 0.18,
95% Cl 2.581 to 0.814, P < 0.001) showed the statistical significance
with IFTA.
Conclusion: The IFTA displayed positive correlation with glomerular class,
serum creatinine and negative correlation with eGFR and age. eGFR might
be a predictor of the IFTA.http://dx.doi.org/10.1016/j.hkjn.2015.08.057
0294
Risk Factors of Diabetic Nephropathy and Relationship Between
Diabetic Retinopathy and Diabetic Nephropathy
Y. Zhang
Department of Nephrology, Shanxi Provincial People’s Hospital, Taiyuan,
Shanxi, China
Objective: The aim of this study was to analyze the risk factors of diabetic
nephropathy (DN), including microalbuminuria and overt nephropathy, and
to explore the relationship between diabetic retinopathy (DR) and DN in dia-
betes mellitus (DM) patients.
Methods: The clinical data of patients with type 2 DM, from June, 2013 to
June, 2014 in our hospital, including genders, age, hypertension, the dura-
tion of DM, levels of fasting blood glucose (FBG), serum hemoglobin A1c
(HbA1c), lipid profile (triglyceride, total cholesterol, low density lipoprotein
cholesterol), blood urea nitrogen (BUN), serum creatinine, estimated
glomerular filtration rate (eGFR), urine albumin-creatinine ratio, history of
smoking, and presence of DR, proliferative DR (PDR) were retrospectively
analyzed. The prevalence of DR and DN was determined. Multivariate logis-
tic regression analysis was performed to determine risk factors, including
DR, associated with DN.
Results: Among 185 DM patients, we observed a prevalence of 31.9% for any
DR and 4.3% for PDR. Microalbuminuria prevalence was 25.4% and overt ne-
phropathy prevalence was 5.4%. The risk factors of microalbuminuria were
presence of hypertension, high levels of HbA1c, BUN, and the presence of
PDR. The risk factors of overt nephropathy were long duration of DM, high
levels of HbA1c, total cholesterol, serum creatinine, and the presence of DR.
Conclusion: DR may be a powerful predictor for the progression of renal
damage in DM patients.http://dx.doi.org/10.1016/j.hkjn.2015.08.058
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Objective: The aim of this study was to observe the effect of different con-
centrations of SB203580 which was inhibitor of P38 mitogen activated pro-
tein kinase (P38MAPK), in process of high glucose-induced
tubularepithelial-myofibroblast transdifferentiation (TEMT).
Methods: The cultured human renal tubular epithelial cells (HK-2) were
divided into 7 groups by the different concentrations of GS and
SB203580, cultured 48 hours. To obverse the morphology of HK-2 cell,
MTT was used to select the more suitable concentration of SB203580 by
calculated the ratio of inhibition in each group, found more suitable
concentration which inhibit rate was 50% (IC50). Selected control
group, high-glucose group and more suitable concentration group (S30group), the protein of P38MAPK, P-P38MAPK and a- smooth muscle actin
(a-SMA) were detected by methods of immunofluorescence and Western
blot using.
Results: (1) Proliferation rate of DMSO group was same as control group
(p > 0.05), high glucose group, S5 group was higher than control group
(p < 0.05), proliferation rate in S10, S20, S30 group was lower than control
group (p < 0.05). Compared with high glucose group, the proliferation of S5,
S10, S20, S30 were all decreased (p < 0.05). (2) The expression of P-P38MAPK
in high glucose group and S30 group is higher than control group (p < 0.05);
compared with high glucose group the expression of P-P38MAPK gradually
decreased in S30 group (p < 0.05), whereas SB203580 did not obviously
inhibit the expression of P38MAPK (p > 0.05). (3) Compared with control
group, the expression of a-SMA was lower than high glucose group, S30 group
(p < 0.05). Compared with high glucose group, 30 mmol/L SB203580 signifi-
cantly inhibited a-SMA expression (p < 0.05).
Conclusion: (1) 30 mmol/L GS can lead to TEMT in HK-2 cell. (2) The more
suitable inhibited concentration of SB203580 in the process of TEMT was
30 umol/L.http://dx.doi.org/10.1016/j.hkjn.2015.08.059
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Objective: The aim of this study was to observe the effect of different con-
centrations of QLT0267 which is inhibitor of integrin-linked kinase (ILK), in
process of high glucose-induced tubularepithelial-myofibroblast transdiffer-
entiation (TEMT).
Methods: The cultured human renal tubular epithelial cells (HK-2) were
divided into 6 groups by the different concentrations of GS and QLT0267,
cultured 48 hours. To obverse the morphology of HK-2 cell, MTT was used
to select the concentration of QLT0267 which was start work in the process
of inhibiting HK-2 cell proliferate. The protein of AKT, P-AKT, a-smooth mus-
cle actin (a-SMA) and ILK were detected by the method of immunofluores-
cence and Western blot using. Observing the differences in each group,
and then explore the role of QLT0267 in the process of TEMT.
Results: (1) Proliferation rate in high glucose group, Q0.5 group was higher
than control group (p < 0.05), Q5, Q15, Q30 group is lower than control
group (p < 0.05). Compared with high glucose group, the proliferation of
Q0.5, Q5, Q15, Q30 were all decreased (p < 0.05). (2) The expression of
p-AKT in high glucose group, Q0.5, Q5, Q15, Q30 group was higher than con-
trol group (p < 0.05). Compared with high glucose group the expression of p-
AKT was gradually decreased in Q0.5, Q5, Q15, Q30 group (p < 0.05),
whereas QLT0267 did not obviously inhibited the expression of AKT. (3)
The protein of ILK expression in control group was lower than others. (4)
Compared with control group, the expression of a-SMA was lower than other
groups (p < 0.05). Compared with high glucose group, a-SMA was decreased
in Q0.5, Q5, Q15, Q30 group (p < 0.05).
Conclusion: (1) 30 mmol/L GS can lead to TEMT in HK-2 cell. (2) The concen-
tration of QLT0267 start work in the process of inhibiting HK-2 cell TEMT was
5 umol/L.http://dx.doi.org/10.1016/j.hkjn.2015.08.060
0304
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Adenine, once called Vitamin B4, is a purine nucleobase with multiple roles
in cellular reproduction, respiration and energy storage. Our previous find-
ings suggested that adenine supplement could ameliorate the inflammation
response in LPS-induced microglial BV2 cells, TNF-a-induced HUVECS and
